Trials
Search / Trial NCT05649241

QuitAid Pilot Feasibility Trial

Launched by UNIVERSITY OF VIRGINIA · Dec 11, 2022

Trial Information

Current as of February 05, 2025

Completed

Keywords

ClinConnect Summary

24 adult smokers were recruited through an independent pharmacy in rural Appalachia were randomized to 1 of 8 treatments: (1) pharmacist delivered QuitAid intervention (Yes vs. No), (2) Combination NRT Gum + NRT Patch (vs. NRT patch), and/or (3) 8 weeks of NRT (vs. standard 4 weeks). All participants received 4 weeks of NRT patch in addition to the components to which they were assigned. Participants completed baseline and 3-month follow-up assessments. The primary outcomes were feasibility of recruitment and randomization, retention, treatment adherence and fidelity.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • smokers must have smoked at least 5 cigarettes per day for the past 6 months
  • be willing to set a quit date in the next 30 days
  • own a cell phone
  • be over 18 years of age
  • not be pregnant or planning to become pregnant in the next 6 months
  • not have any medical contraindications to using NRT
  • Exclusion Criteria:
  • Those who are pregnant or plan to be
  • Those under 18 years of age
  • Those with a medical contradiction
  • Those who do not own a cell phone
  • Those who have not smoked 5 cigarettes per day for the last 6 months
  • Those who are unwilling to set a quit date within 30 days

Trial Officials

Melissa Little, PhD

Principal Investigator

University of Virginia

About University Of Virginia

The University of Virginia (UVA) is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a focus on interdisciplinary collaboration, UVA leverages its extensive resources and expertise in various fields, including medicine, engineering, and public health, to drive cutting-edge studies that address pressing health challenges. The university's clinical trial programs aim to translate scientific discoveries into effective treatments, ensuring the highest standards of ethical practice and participant safety. Through its strong emphasis on community engagement and education, UVA fosters a culture of research that not only contributes to the scientific community but also enhances the well-being of the populations it serves.

Locations

Charlottesville, Virginia, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials